-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on Addus HomeCare, Lowers Price Target to $92

Benzinga·05/15/2026 13:46:40
Listen to the news
Barclays analyst Andrew Mok maintains Addus HomeCare (NASDAQ:ADUS) with a Underweight and lowers the price target from $102 to $92.